General Information of Drug Off-Target (DOT) (ID: OTSTC5B5)

DOT Name StAR-related lipid transfer protein 3 (STARD3)
Synonyms Metastatic lymph node gene 64 protein; MLN 64; Protein CAB1; START domain-containing protein 3; StARD3
Gene Name STARD3
Related Disease
Prostate cancer ( )
Advanced cancer ( )
Breast cancer ( )
Breast carcinoma ( )
Breast neoplasm ( )
Colon cancer ( )
Colon carcinoma ( )
Gastric cancer ( )
Neoplasm ( )
Osteoporosis ( )
Prostate carcinoma ( )
Prostate neoplasm ( )
Signet ring cell carcinoma ( )
Stomach cancer ( )
UniProt ID
STAR3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1EM2; 5I9J; 6TQR; 6TQU
Pfam ID
PF10457 ; PF01852
Sequence
MSKLPRELTRDLERSLPAVASLGSSLSHSQSLSSHLLPPPEKRRAISDVRRTFCLFVTFD
LLFISLLWIIELNTNTGIRKNLEQEIIQYNFKTSFFDIFVLAFFRFSGLLLGYAVLRLRH
WWVIAVTTLVSSAFLIVKVILSELLSKGAFGYLLPIVSFVLAWLETWFLDFKVLPQEAEE
ERWYLAAQVAVARGPLLFSGALSEGQFYSPPESFAGSDNESDEEVAGKKSFSAQEREYIR
QGKEATAVVDQILAQEENWKFEKNNEYGDTVYTIEVPFHGKTFILKTFLPCPAELVYQEV
ILQPERMVLWNKTVTACQILQRVEDNTLISYDVSAGAAGGVVSPRDFVNVRRIERRRDRY
LSSGIATSHSAKPPTHKYVRGENGPGGFIVLKSASNPRVCTFVWILNTDLKGRLPRYLIH
QSLAATMFEFAFHLRQRISELGARA
Function
Sterol-binding protein that mediates cholesterol transport from the endoplasmic reticulum to endosomes. The sterol transport mechanism is triggered by phosphorylation of FFAT motif that leads to membrane tethering between the endoplasmic reticulum and late endosomes via interaction with VAPA and VAPB. Acts as a lipid transfer protein that redirects sterol to the endosome at the expense of the cell membrane and favors membrane formation inside endosomes. May also mediate cholesterol transport between other membranes, such as mitochondria membrane or cell membrane. However, such results need additional experimental evidences; probably mainly mediates cholesterol transport from the endoplasmic reticulum to endosomes. Does not activate transcriptional cholesterol sensing. Able to bind other lipids, such as lutein, a xanthophyll carotenoids that form the macular pigment of the retina.
Tissue Specificity Expressed in retina.
KEGG Pathway
Cholesterol metabolism (hsa04979 )
Reactome Pathway
Pregnenolone biosynthesis (R-HSA-196108 )

Molecular Interaction Atlas (MIA) of This DOT

14 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Prostate cancer DISF190Y Definitive Altered Expression [1]
Advanced cancer DISAT1Z9 Strong Altered Expression [1]
Breast cancer DIS7DPX1 Strong Altered Expression [2]
Breast carcinoma DIS2UE88 Strong Altered Expression [2]
Breast neoplasm DISNGJLM Strong Altered Expression [3]
Colon cancer DISVC52G Strong Biomarker [4]
Colon carcinoma DISJYKUO Strong Biomarker [4]
Gastric cancer DISXGOUK Strong Altered Expression [5]
Neoplasm DISZKGEW Strong Biomarker [6]
Osteoporosis DISF2JE0 Strong Biomarker [7]
Prostate carcinoma DISMJPLE Strong Altered Expression [8]
Prostate neoplasm DISHDKGQ Strong Biomarker [9]
Signet ring cell carcinoma DISVCUCR Strong Genetic Variation [10]
Stomach cancer DISKIJSX Strong Altered Expression [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 14 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of StAR-related lipid transfer protein 3 (STARD3). [11]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of StAR-related lipid transfer protein 3 (STARD3). [13]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Urethane DM7NSI0 Phase 4 Urethane increases the expression of StAR-related lipid transfer protein 3 (STARD3). [12]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of StAR-related lipid transfer protein 3 (STARD3). [14]
------------------------------------------------------------------------------------

References

1 First-of-its-kind STARD(3) Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent.ACS Med Chem Lett. 2019 Feb 20;10(4):475-480. doi: 10.1021/acsmedchemlett.8b00509. eCollection 2019 Apr 11.
2 Elevated levels of StAR-related lipid transfer protein 3 alter cholesterol balance and adhesiveness of breast cancer cells: potential mechanisms contributing to progression of HER2-positive breast cancers.Am J Pathol. 2015 Apr;185(4):987-1000. doi: 10.1016/j.ajpath.2014.12.018. Epub 2015 Feb 12.
3 Expression of MLN64 influences cellular matrix adhesion of breast cancer cells, the role for focal adhesion kinase.Int J Mol Med. 2010 Apr;25(4):573-80.
4 High efficiency reconstitution of a human-mouse chimeric Fab of CAb-1 antibody specific to human colon cancer.Scand J Immunol. 2008 Jul;68(1):12-21. doi: 10.1111/j.1365-3083.2008.02087.x. Epub 2008 May 13.
5 PPP1R1B-STARD3 chimeric fusion transcript in human gastric cancer promotes tumorigenesis through activation of PI3K/AKT signaling.Oncogene. 2014 Nov 13;33(46):5341-7. doi: 10.1038/onc.2013.472. Epub 2013 Nov 25.
6 Ioncopy: anovel method for calling copy number alterations in amplicon sequencing data including significance assessment.Oncotarget. 2016 Mar 15;7(11):13236-47. doi: 10.18632/oncotarget.7451.
7 MLN64 deletion suppresses RANKL-induced osteoclastic differentiation and attenuates diabetic osteoporosis in streptozotocin (STZ)-induced mice.Biochem Biophys Res Commun. 2018 Nov 10;505(4):1228-1235. doi: 10.1016/j.bbrc.2018.10.007. Epub 2018 Oct 13.
8 Increased metastatic lymph node 64 and CYP17 expression are associated with high stage prostate cancer.J Endocrinol. 2007 Jul;194(1):55-61. doi: 10.1677/JOE-07-0131.
9 Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model.Prostate. 2007 Jan 1;67(1):83-106. doi: 10.1002/pros.20505.
10 Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population.Gene. 2014 Feb 10;535(2):225-32. doi: 10.1016/j.gene.2013.11.030. Epub 2013 Nov 28.
11 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
12 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
13 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
14 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.